Company / Free Cash Flow per Share
Theravance Biopharma, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$4.82
FY2025
5-year range
-$3.45 / $4.82
FY2021-FY2025
Trend
+2053.7%
vs FY2024
Sector context
#21 of 192
Health Care
What the data says
Free Cash Flow per Share changed +2054% YoY in FY2025, a notable deviation from the 9-year average annual change of +233%.
Based on SEC 10-K filings.
4.82 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.45 to $4.82 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 192This company $4.82 Sector average -$19.84
▼
+124.3% above sector average
Key checks
Key Insights
- Theravance Biopharma, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 2053.7% year-over-year.
- Ranks #21 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.82 | +2053.7% |
| FY2024 | -$0.25 | +45.4% |
| FY2023 | -$0.45 | +86.9% |
| FY2022 | -$3.45 | -5.1% |
| FY2021 | -$3.28 | +27.1% |
| FY2020 | -$4.51 | -23.4% |
| FY2019 | -$3.65 | -96.5% |
| FY2018 | -$1.86 | +51.7% |
| FY2017 | -$3.85 | -44.6% |
| FY2016 | -$2.66 | +30.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026